牛コロストラム市場-2023年～2030年

概要

牛コロストラムの世界市場は、2022年に12億米ドルに達し、2023年から2030年の予測期間にCAGR 5.2%で成長し、2030年には18億米ドルに達すると予測されています。

牛コロストラムの需要は、2024-2031年の予測期間中に大幅に増加している、

消費者は、牛コロストラムを様々な用途、特に乳児用製品に取り入れるようになってきています。これらの抗体は、乳幼児や動物の感染症から守り、健康的な成長を促進する重要な役割を担っています。さらに、牛の初乳は必須栄養素とタンパク質が豊富なことでも評価されています。

さらに、製造企業は革新的な牛コロストラム製品を投入することでポートフォリオを多様化しており、これは市場規模の拡大と市場での存在感の拡大を狙った戦略です。例えば、2022年11月、PanTheryxcompanyは、新しいLife's First Naturals PROウシ（牛）コロストラムサプリメントを発売した、それは免疫因子、保護タンパク質、成長因子、プレバイオティクスの包括的なソースであるColostrumOneを搭載しています。

栄養補助食品セグメントは、牛コロストラムの世界市場で最大のシェアを占めています。同様に、アジア太平洋地域は生乳生産率が高く、メーカーも革新的な牛用初乳製品を開発しているため、世界の牛コロストラム場を牽引しています。

市場力学

初乳ガンの増加

プロバイオティクス障害は初乳ガンを引き起こす可能性があり、初乳ガンの有病率は消費者の間で上昇しています。例えば、世界保健機関（WHO）の報告によると、大腸がんは世界で3番目に多いがんで、全がん患者の約10％を占め、がん関連死亡の世界第2位の原因となっています。大腸がんは高齢者に多く、50歳以上の患者が大半を占める。

さらに、製造企業はより多くの消費者層を惹きつけるため、幅広い製品の開発に注力しています。例えば、2022年11月、APSバイオ・グループとサンプラス社は、新しい牛コロストラム製品を開発するための複数年にわたる戦略的パートナーシップを発表しました。この戦略的提携により、APSはサンプラスのnatrapure cbps粉ミルクに初乳の基礎タンパク質と免疫グロブリンgを配合した新製品をデビューさせる予定です。

製品開発の増加

牛コロストラムはタンパク質やビタミンなどの栄養価が高いことで知られているため、製品開発者は牛コロストラムを様々な機能性食品や栄養補助食品に取り入れています。また、免疫系をサポートする抗体も含まれています。その結果、製品開拓は世界の牛コロストラム市場の牽引役となります。

さらに、大手企業はコロストラム市場を戦略的に開拓・拡大しています。例えば、2022年12月、BlendhubとColoPlus ABの共同イノベーションにより、がんやHIVの患者、トップアスリート、高齢者の免疫システムの回復を助ける牛コロストラムをベースにしたColoPlusフォーミュラが発売されました。この提携は、牛の初乳の生物活性特性と自然栄養に基づく特許取得済みの革新的な栄養補助食品の開発と商品化を目的とするものです。

乳糖不耐症

消費者の中には、乳糖を消化することができず、牛コロストラムベースの製品を消化できない人がいます。乳糖不耐症の有病率は増加傾向にあり、例えば2023年の製薬レポートによると、人類の約65％が乳幼児期以降に乳糖を消化する能力が低下しており、東アジア地域で最も一般的です。したがって、このような高い有病率は、消費者基盤が小さい場合には市場を制限する可能性があります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • コロストラムがんの有病率の増加
    • 製品開発の増加
  • 抑制要因
    • 乳糖不耐症
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• DMIの見解

第6章 COVID-19分析

第7章 性質別

• オーガニック
• 従来

第8章 製品タイプ別

• ホール
  • ホールコロストラムパウダー
  • スキムコロストラムパウダー
  • スペシャルティコロストラムパウダー
• コロストラム最終製品
  • カプセル
  • チュアブル錠
  • 個別小袋
  • 特殊配合製品

第9章 用途別

• 食品
• 化粧品
• 栄養補助食品
• その他

第10章 流通チャネル別

• ハイパーマーケット／スーパーマーケット
• コンビニエンスストア
• 専門店
• ドラッグストア
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第12章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第13章 企業プロファイル

• Colostrum BioTec GmbH
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• Zuche Pharmaceuticals.
• Biodane Pharma A/S
• Agati Healthcare
• mcePharma
• Cure Nutraceutical PVT. LTD.
• PanTheryx, Inc.
• NOW Health Group, Inc.
• Sterling Technology
• Aadvik Foods

第14章 付録

Overview

Global Cow Colostrum Market reached US$ 1.2 billion in 2022 and is expected to reach US$ 1.8 billion by 2030, growing with a CAGR of 5.2% during the forecast period 2023-2030.

The demand for cow colostrum is rising significantly over the forecast period of 2024-2031,

Consumers are increasingly incorporating cow colostrum into a variety of applications, particularly in infant products, due to its exceptional nutritional content and high levels of antibodies. These antibodies play a crucial role to safeguard against infections and promoting healthy growth in both infants and animals. Additionally, cow colostrum is valued for its abundance of essential nutrients and proteins.

In addition, manufacturing companies are diversifying their portfolios by introducing innovative cow colostrum products, a strategy aimed at increasing their market sizes and expanding their market presence. For instance, in November 2022, PanTheryxcompany launched a new Life's First Naturals PRO bovine (cow) colostrum supplement, it is powered by ColostrumOne, a comprehensive source of immune factors, protective proteins, growth factors, and prebiotics.

The nutritional and dietary supplements segment accounts the largest share in global cow colostrum market. Similarly, Asia-Pacific region has been a dominant force as the production rate of milk is high in this region, as well as manufactures also developing innovative cow colostrum products, which can help in driving the global cow colostrum market.

Dynamics

Increasing Prevalence Of Colostrum Cancers

The probiotic disorder can cause colostrum cancer, and the prevalence of colostrum cancer is rising among consumers. For instance, according to a World Health Organization (WHO) report, colorectal cancer is the third most common cancer worldwide, accounting for approximately 10% of all cancer cases, and is the second leading cause of cancer-related deaths worldwide. It predominantly affects older individuals, with the majority of cases occurring in people aged 50 and above.

In addition, manufacturing companies are focusing on developing a wide range of products to attract larger consumer bases. For instance, in November 2022, APS Bio Group and Sunplus, announced a multi-year strategic partnership to develop new bovine colostrum products. Through the strategic partnership, APS will debut its new colostrum basic protein and immunoglobulin g formula in sunplus's natrapure cbps milk powder.

Increase in Product Development

Product developers are incorporating cow colostrum into various functional foods and dietary supplements, as cow colostrum is known for its high nutritional content, including proteins, and vitamins. It offers antibodies that contribute to immune system support. As a result product development can help in driving the global cow colostrum market.

Furthermore, major companies are strategically developing and expanding the colostrum market. For instance, in December 2022, collaborative innovation between Blendhub and ColoPlus AB launched a ColoPlus formula based on bovine colostrum to help restore the immune system in cancer or HIV patients, top athletes, or the elderly. This collaboration is to develop and commercialize patented innovative nutraceutical food products based on the bioactive properties of bovine colostrum and natural nutrition.

Lactose Intolerance

Some consumers might have an inability to digest the lactose, they are unable to digest cow-colostrum-based products. The prevalence of lactose intolerance is increasing, for instance, according to a pharma report of 2023, approximately 65 percent of the human population has a reduced ability to digest lactose after infancy, and it is most common in the East Asian region. Therefore, such a high prevalence rate can limit the market for smaller consumer bases.

Segment Analysis

The global cow colostrum market is segmented based on nature, product type, application, distribution channel, and region.

Increase in Demand for Effective Natural Organic Nutritional and Dietary Supplements

The nutritional and dietary supplements segment accounts for the largest share of the global cow colostrum market, consumers are adopting these cow colostrum as they are rich in immunoglobulins, antibodies that play a vital role in supporting the immune system. The regular consumption of colostrum supplements may help enhance the body's defense mechanisms against infections and illnesses.

Furthermore, supplement-producing companies are launching innovative products. For instance, in August 2022, the Roots Brands is unveiling a one-of-a-kind blend of hydrolyzed bovine collagen and whole colostrum powder as a youth-enhancing supplement, which is Dubbed Give Me Back My Youth (GMBMY), is sourced from cows. It helps to promote type types I and Ill collagen in humans, and also boosts skin hydration, enhancing suppleness and minimizing wrinkles.

Geographical Penetration

High Milk Production, and Product Development

Asia-Pacific has been a dominant force in the global cow colostrum market and its significant growth. From ancient times milk and milk products have been part of the consumer's diet in this region, also the demand for cow colostrum products is rising especially in infant foods as they provide antibodies and enhance the immune health.

Furthermore, the production rate for milk is high in this region, for instance, according to the Ministry of Fisheries, Animal Husbandry & Dairying reports the milk industry has raised, since the launch of Operation Flood program. India is the largest producer of milk in the world, contributing 23% of global milk production.

In addition, the manufacturing companies in this region are also launching products to support the rising market demand. For instance, in May 2020, the Surat District Cooperative Milk Producers Union Limited developed cow colostrum powder' Sumul Immune powder, an immunity booster to protect COVID-19-positive patients, it has albumin, globulin, and Gama globulin. It is rich in vitamins A, D, E, and K and also contains 300 types of enzymes to increase gut health.

Competitive Landscape

The major global players in the market include Colostrum BioTec GmbH, Zuche Pharmaceuticals., Biodane Pharma A/S, Agati Healthcare, mcePharma, Cure Nutraceutical PVT. LTD., PanTheryx, Inc., NOW Health Group, Inc., Sterling Technology, and Aadvik Foods.

COVID-19 Impact Analysis

The pandemic has had diverse effects on various markets, including the food and healthcare sectors. Many governments have imposed lockdown restrictions which has disrupted the supply chain, changes in consumer behavior, and economic challenges can influence markets. Hence, COVID-19 has shown a negative impact global cow colostrum market.

By Nature

• Organic
• Conventional

By Product Type

• Whole
• Whole Colostrum Powder
• Skim Colostrum Powder
• Specialty Colostrum Powder
• Colostrum Finished Products
• Capsules
• Chewable Tablets
• Individual Sachets
• Specially Formulated Products

By Application

• Food
• Cosmetics
• Nutritional and Dietary Supplements
• Others

By Distribution Channel

• Hypermarket/Supermarket
• Convenience Store
• Specialty Stores
• Drug Stores
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In May 2022, Glanbia Nutritionals acquired Sterling Technology, a South Dakota-based manufacturer of dairy bioactive solutions derived from bovine colostrum. Glanbia Nutritionals purchased for $60 million plus deferred consideration.
• In November 2022, PanTheryx launches extra- strength colostrum supplement which is Life's First Naturals PRO, an extra-strength immune support and digestive health supplement formulated for the health care practitioner channel.

Why Purchase the Report?

• To visualize the global cow colostrum market segmentation based on nature, product type, application, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of cow colostrum market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The global cow colostrum market report would provide approximately 70 tables, 63 figures and 210 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

• 1.1.Research Methodology
• 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

• 3.1.Snippet by Nature
• 3.2.Snippet by Product Type
• 3.3.Snippet by Application
• 3.4.Snippet by Distribution Channel
• 3.5.Snippet by Region

4.Dynamics

• 4.1.Impacting Factors
  • 4.1.1.Drivers
    • 4.1.1.1.Increasing Prevalence of Colostrum Cancers
    • 4.1.1.2.Increase in Product Development
  • 4.1.2.Restraints
    • 4.1.2.1.Lactose Intolerance
  • 4.1.3.Opportunity
  • 4.1.4.Impact Analysis

5.Industry Analysis

• 5.1.Porter's Five Force Analysis
• 5.2.Supply Chain Analysis
• 5.3.Pricing Analysis
• 5.4.Regulatory Analysis
• 5.5.DMI Opinion

6.COVID-19 Analysis

• 6.1.Analysis of COVID-19
  • 6.1.1.Scenario Before COVID
  • 6.1.2.Scenario During COVID
  • 6.1.3.Scenario Post COVID
• 6.2.Pricing Dynamics Amid COVID-19
• 6.3.Demand-Supply Spectrum
• 6.4.Government Initiatives Related to the Market During Pandemic
• 6.5.Manufacturers Strategic Initiatives
• 6.6.Conclusion

7.By Nature

• 7.1.Introduction
  • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
  • 7.1.2.Market Attractiveness Index, By Nature
• 7.2.Organic*
  • 7.2.1.Introduction
  • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3.Conventional

8.By Product Type

• 8.1.Introduction
  • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.1.2.Market Attractiveness Index, By Product Type
• 8.2.Whole*
  • 8.2.1.Introduction
  • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.2.3.Whole Colostrum Powder
  • 8.2.4. Skim Colostrum Powder
  • 8.2.5. Specialty Colostrum Powder
• 8.3.Colostrum Finished Products
  • 8.3.1.Capsules
  • 8.3.2.Chewable Tablets
  • 8.3.3.Individual Sachets
  • 8.3.4. Specially Formulated Products

9.By Application

• 9.1.Introduction
  • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2.Market Attractiveness Index, By Application
• 9.2.Food*
  • 9.2.1.Introduction
  • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3.Cosmetics
• 9.4.Nutritional and Dietary Supplements
• 9.5.Others

10.By Distribution Channel

• 10.1.Introduction
  • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 10.1.2.Market Attractiveness Index, By Distribution Channel
• 10.2.Hypermarket/Supermarket*
  • 10.2.1.Introduction
  • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3.Convenience Store
• 10.4.Specialty Stores
• 10.5.Drug Stores
• 10.6.Others

11.By Region

• 11.1.Introduction
  • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2.Market Attractiveness Index, By Region
• 11.2.North America
  • 11.2.1.Introduction
  • 11.2.2.Key Region-Specific Dynamics
  • 11.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
  • 11.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.7.1.U.S.
    • 11.2.7.2.Canada
    • 11.2.7.3.Mexico
• 11.3.Europe
  • 11.3.1.Introduction
  • 11.3.2.Key Region-Specific Dynamics
  • 11.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
  • 11.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.7.1.Germany
    • 11.3.7.2.UK
    • 11.3.7.3.France
    • 11.3.7.4.Italy
    • 11.3.7.5.Russia
    • 11.3.7.6.Rest of Europe
• 11.4.South America
  • 11.4.1.Introduction
  • 11.4.2.Key Region-Specific Dynamics
  • 11.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
  • 11.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.7.1.Brazil
    • 11.4.7.2.Argentina
    • 11.4.7.3.Rest of South America
• 11.5.Asia-Pacific
  • 11.5.1.Introduction
  • 11.5.2.Key Region-Specific Dynamics
  • 11.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
  • 11.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.7.1.China
    • 11.5.7.2.India
    • 11.5.7.3.Japan
    • 11.5.7.4.Australia
    • 11.5.7.5.Rest of Asia-Pacific
• 11.6.Middle East and Africa
  • 11.6.1.Introduction
  • 11.6.2.Key Region-Specific Dynamics
  • 11.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Nature
  • 11.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12.Competitive Landscape

• 12.1.Competitive Scenario
• 12.2.Market Positioning/Share Analysis
• 12.3.Mergers and Acquisitions Analysis

13.Company Profiles

• 13.1.Colostrum BioTec GmbH*
  • 13.1.1.Company Overview
  • 13.1.2.Product Portfolio and Description
  • 13.1.3.Financial Overview
  • 13.1.4.Key Developments
• 13.2.Zuche Pharmaceuticals.
• 13.3.Biodane Pharma A/S
• 13.4.Agati Healthcare
• 13.5.mcePharma
• 13.6.Cure Nutraceutical PVT. LTD.
• 13.7.PanTheryx, Inc.
• 13.8.NOW Health Group, Inc.
• 13.9.Sterling Technology
• 13.10.Aadvik Foods

LIST NOT EXHAUSTIVE

14.Appendix

• 14.1.About Us and Services
• 14.2.Contact Us